FIANOSTICS develops, manufactures and sells highly sensitive fluorescence immunoassays based on a new metal enhanced fluorescence platform. At present FIANOSTICS focusses on diseases of bone and cartilage. Later on this will be complemented by assays to study neurological disorders, because clinical research in those areas, which become more and more important due to the ongoing demographic changes, will significantly benefit from high sensitivity Biomarker tests.
Viktor Kaplan-Straße 2
2700 Wiener Neustadt
Lower Austria
Contact: Gerhard Hawa (General Manager / Founder)
Telephone: +43 (2622) 27514
Email: office@fianostics.at
Website